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THE EFFECT OF INTRAVENOUS FAT ON SERUM LIPIDS*
MARK ALLEN EVERETT, M.D., WALTER D. BLOCK, PH.D. AND
ARTHUR C. CURTIS, M.D.
Knowledge concerning the biochemical changes
associated with the disposition of ingested or
injected lipids has increased greatly during the
past ten years. The intravascular mechanics of
lipid transport have received much attention,
particularly with respect to the so-called "clearing
factor" and "lipoprotein lipase" (1—4), and to the
action of heparin on this factor (5—8).
Investigation of lipid disposition by the body
was dependent on the development of a fat
emulsion suitable for intravenous administration.
The problem of developing such an emulsion has
now been largely solved (9—13).
In general, normal humans respond to the
intravenous administration of an emulsion of
triglycerides with an initial rapid increase in
serum lipid values, followed by a decrease either
during or immediately following the infusion
(10, 12). The time which elapses before a return
of serum lipids to pre-treatment levels varies in
normal subjects from 3 to 11 hours. The rate of
removal of excess lipid seems to depend both
upon individual systemic factors and upon the
characteristics of the fat emulsion.
In 1955, Lever et al (7) showed that intra-
venous fat has a lipid-lowering effect on the serum
of patients with idiopathic hyperlipemia.
All of these studies contributed to our knowl-
edge of lipid transport, and led to the formula-
tion of various theories (2—4).
In most of the investigations reported, the
laboratory methods were limited to one or two
technics. We felt that utilization of a combina-
tion of laboratory technics might afford at least
partial confirmation of existing theories of lipid
transport.
This study represents an attempt to evaluate
the chemical changes involved in lipid transport.
Specifically, it deals with the effects of intra-
venous fat administration on normal individuals
and on a patient with idiopathic hyperlipemia.
Quantitative determinations of total serum
lipids, total cholesterol, cholesterol esters, and
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phospholipids were carried out. In addition, each
serum was analyzed by free moving-boundary
electrophoresis.
METHODS
600 cc. of fat emulsion, Lipomul-IV,' were
given to three normal male subjects, and to one
patient with idiopathic hyperlipemia. The
Lipomul-IV fat emulsion had the following
composition: cottonseed oil, 15%; glucose, 4%;
soybean phosphatid, 1.2%; and pluronic acid
F68, a stabilizer, 0.3%. Complete hepatic, renal,
and cardio-vascular studies, both clinical and
laboratory, were found to be within physiological
limits in all cases. Subjects were kept on routine
hospital diets. No significant weight changes
occurred during the experiments.
Infusions were begun at 8:00 n.m. with the
patient fasting, and were complete in 3 to 3j
hours. Blood samples were collected at fasting, at
the termination of the infusion, and at fasting 24
hours after the beginning of the fat infusion.
Free moving-boundary electrophoresis was
carried out on fresh serum, using veronnf buffer
at pH 8.6 and ionic strength 0.1 i, according to
the method of Tiselius (14). Quantitation of the
protein components was carried out by the
method of Tiseius and Kabat (15). Total serum
lipids were determined by the method of Bragdon
(16), total cholesterol and cholesterol esters by
the Schoenheimer-Sperry method (17), and
phospholipids by the Fiske-SubbaRow method
(18). Triglycerides were calculated, using the
other lipid data (16).
RE5ULT5
Normal Individuals
Quantitative electrophoretic values on the
three normal subjects are presented in Table I.
Fig. I shows the electrophoretic patterns of one
of these subjects (. 3, V. H.) at the fasting state,
at the end of the infusion, and 24 hours after the
beginning of the infusion. These patterns are
1 Prepared and supplied by The Upjohn Com-
pany, Kalamazoo, Michigan.
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TABLE I
Quantitative electrophoretic values on normal and idiopathic hyperlipemic subjects before, at
the termination of, and 24 hours after the i. v. administration of a fat emulsion. Results
expressed as per cent of total protein
Subject
Fasting Termination of IV 24 Hr. Fasting
A1b
mm
Globulins
at as 7
ATh
mm
Globulins
as as
A
mm
Globulins
as as P
Normals
1. F. S
2. J. S
3. V.11
Hyperlipemics
E. B.—Exp. 1
E. B.—Exp. 2
%
65.7
70.1
64.8
47.1
67.5
%
4.1
3.7
4.2
2.9
2.2
%
9.2
6.0
6.8
13.9
13.9
%
14.5
11.5
13.4
27.0
11.1
%
6.5
8.7
10.8
9.1
5.3
%
68.1
74.3
68.7
62.7
72.5
%
6.4
6.8
10.0
8.2
10.3
%
10.6
4.3
4.6
14.3
5.7
%
10.1
6.2
5.2
5.5
4.6
%
4.8
8.4
11.5
9.3
6.9
%
67.2
66.1
68.7
49.6
66.0
%
4.3
3.4
3.6
4.5
9.0
%
11.2
6.4
6.9
14.8
10.2
%
13.0
13.1
12.1
20.0
5.2
%
4.3
11.0
8.7
11.1
9.6
NORMAL VII.
Fig. I. Electrophoretic Patterns of a NormalSubject (V. H.) Given Intravenous Fat Emulsion.(A) Fasting Pattern: (B) Pattern Obtained at the
Termination of the Infusion: (C) Pattern Ob-
tained on the Fasting Sample 24 Hours After the
Beginning of the Fat Infusion.
typical of the results obtained on all three normal
individuals.
The fasting electrophoretic data show no
abnormalities. At the termination of the intra-
venous fat infusion (Lipomul-IV) there were
decreases in the /3- and/or argiobulin areas, and
increases in the a i-globulin area. At the end of
24 hours, the fasting electrophoretic pattern had
returned to normal. Although rate differences did
occur, all the normal subjects studied demon-
strated this shift from the /3- to the a i-globulin
area, and a return to normal within 24 hours
after completion of the infusion.
Quantitative values for total lipid, total
cholesterol, cholesterol esters, and phospholipids
on the three normal subjects are summarized in
Table II. At the end of the infusion, large increases
TABLE II
Quantitative lipid values on the serum of normal
individuals, before, at the termination of, and
24 hours after the intravenous administration of a
fat emulsion.
Total Lipids
Triglycerides
Total
Cholesterol
Cholesterol
Esters
Phospholipid
Total Lipids
Triglycerides
Total
Cholesterol
Cholesterol
Esters
Phospholipid
Total Lipids
Triglycerides
Total
Cholesterol
Cholesterol
Esters
Phospholipid
* Values are expressed as mg. % except in the
case of cholesterol esters, which are expressed as
per cent of total cholesterol.
'ArT,,,,
cib.
A
cib.
B
54
alb.
C
1 LipidsDetermined'
F Termi-
•ast- nationing of IVSubject
1. F. S.
2. J. S.
3. V.11.
818
44
316
62
325
846
219
205
17
399
582
12
241
67
171
24 Hr.
Fasting
456
Trace
160
51
240
1082
442
150
50
439
518
3
218
60
174
3177
2360
296
54
413
2656
1770
257
63
519
2085
1444
225
63
294
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in total lipids, principally the triglyceride frac-
tion, were observed. Little change in cholesterol
values resulted from the infusion. Phospholipids
were somewhat increased, averaging 110 mg. %
higher than the fasting values. The fasting sample
taken 24 hours later showed a return to normal
or below normal in all values except those for
total lipids and triglycerides in subject #2 (J. S.).
Even in this case, the 24 hour values were
markedly lower than those obtained at the end of
the infusion.
A comparison of the results obtained in the
lipid partition with those obtained by electro-
phoresis shows that the changes in lipid values
parallel the shift from j- to a i-globulin.
I4YPERLIPEMtA ED. EXP I
-
Fig. II. Electrophoretic Patterns of a Hyper-lipemic Patient (E. B.) Given Intravenous Fat
Emulsion. Experiment I, Patient Previously tJn-
treated. (A) Fasting Pattern: (B) Pattern Ob-
tained at the Termination of the Infusion: (C)
Pattern Obtained on the Fasting Sample 24 Hours
After the Beginning of the Fat Infusion.
Idiopathic Hyperlipemia
Fig. II shows the electrophoretic patterns ob-
tained in the first experiment on patient E. B.
Quantitative values for the various protein
components are given in Table I (E. B., xp. 1).
The fasting electrophoretic pattern on the first
day of this experiment was grossly abnormal,
characterized by splintering of the peaks in the
a- and f3-globulin regions. Both the a- and 3-
globulin fractions are elevated; the aj-globulin
fraction is low.
At the termination of the first infusion of
Lipomul-IV, $-globulin is markedly decreased,
a i-globulin markedly increased. Attention should
also be called to the presence of a pre-albumin
peak in the electrophoretic pattern obtained at
the termination of the infusion.
In the fasting sample taken 24 hours later, the
quantitative electrophoretic data show a
tendency to return to pre-treatment levels. It can
be seen from Fig. II that the splintering in the
a- and p3-globulin regions is reappearing, and
that the a2-globulin peak is smaller than in the
previous sample.
Quantitative lipid analyses obtained in the
first experiment on the hyperlipemic patient are
recorded in Table III (E. B., Exp. 1). Both cho-
lesterol and phospholipid values are markedly
elevated in the pre-treatment fasting sample.
The total lipid value was greatly elevated.
At the termination of the first Lipomul-IV
TABLE III
Quantitative lipid values on the serum of a patient with idiopathic hyperlipemia, and changes
occurring as a result of serial intravenous fat infusions
Subject Lipids Determinedt
First Day Second Day ThirdDay*
Fourth
Day
.Fasting Termina-tion of IV Fasting
Termina-
tion of IV Fasting Fasting
E. B.—Exp. 1
E. B.—Exp. 2
Total Lipid
Total Cholesterol
Cholesterol Esters
Phospholipid
Total Lipid
Triglycerides
Total Cholesterol
Cholesterol Esters
Phospholipid
5012
782
66
687
2137
888
560
73
413
2632
711
62
665
4382
3061
535
71
528
2775
666
63
403
3668
2153
623
69
600
2855
687
68
710
5854
4372
584
67
633
1764
466
64
577
4169
2540
644
65
700
1694
660
64
535
2927
1428
677
71
493
* Intravenous fat infusion given (Lipomul-IV)
t Values expressed as mg.%, except in the case of cholesterol esters, which are expressed as per cent
of total cholesterol.
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infusion, phospholipids are essentially unchanged.
Cholesterol is slightly decreased. There is a
marked decrease in total lipids.
Twenty-four hours later, the total lipids
remain much lower than in the original sample,
although the value is slightly higher than that
obtained at the end of the infusion. Cholesterol
has again decreased slightly. A marked drop in
phospholipids has occurred.
Results of this experiment (Exp. 1) on the
hyperlipemic patient were qualitatively similar
to those obtained on the normal individuals.
Although both the electrophoretic pattern and
the lipid levels were initially grossly abnormal,
here too the changes in lipid values parallel the
shift from fi- to a i-globulin.
On the second day of the first experiment (E.
B., Exp. 1) after taking the fasting 24 hour
sample, another fat infusion (Lipomul-IV) was
administered, and lipid values determined.
Results of this experiment are recorded in Table
III. At the termination of the second infusion
there was no significant change in total lipids,
or in cholesterol. Phospholipids increased to a
value slightly higher than the pre-treatment
level. The fasting sample obtained on the third
day of this experiment showed (Table III, Exp.
1) a marked decrease in all the lipid fractions
studied.
On the third day of this experiment, another
fat infusion was given, and the lipid fractions
determined on a fasting sample taken 24 hours
later. A further decrease in total lipids occurred,
although this value was still considerably above
the normal value for serum total lipids. Phos-
pholipid values remained considerably lower than
the original values. Although there was an
increase in total cholesterol over the previous
sample, this value was still lower than the pre-
treatment level.
Quantitative values for the various protein
fractions on the fasting sample taken 24 hours
after the third intravenous fat infusion (Exp. 1)
although not shown, were essentially the same as
those obtained on the sample taken 24 hours
after the first infusion. The electrophoretic
patterns indicated no marked qualitative differ-
ences from the first 24 hour sample. Quantitative
values were almost identical in the two samples.
Over a period of months, the serum of this
hyperlipemic patient (E. B.) gradually returned
to its original high lipid values. An attempt was
therefore made to repeat the lipid-lowering effect
of Lipomul-IV on this same patient one year
later. It should be noted here that the Lipomul-
IV used in this second experiment contained a
more highly purified phosphatide fraction than
the Lipomul-IV used in the first experiment.2
Electrophoretic patterns obtained in this
second experiment are shown in Fig. III. The
quantitative electrophoretic data are recorded
in Table I (E. B., Exp. 2), On the pre-treatment
sample, the arglobulin peak is split, and the
quantitative value for ai-globulin is elevated.
The value for fl-globulin is within the normal
range. a1-Globulin is somewhat low.
The sample taken at the termination of the
first infusion of Lipomul-IV shows a marked
increase in a i-globulin. Both a2- and fl-globulin
are markedly decreased. This sample also shows
the presence of a pre-albumin peak.
Twenty-four hours later, ai-globulin is still
elevated, while the fl-globulin value is still low.
a2-Globulin is also slightly low.
Serum lipid values obtained in the second
experiment on the hyperlipemic patient are
recorded in Table III. The pre-treatment levels
are lower than those found during the same
period in the previous experiment. Phospholipids
are essentially normal. Total cholesterol is high,
and total lipids are very high.
At the termination of the infusion, total lipids
are greatly increased. This finding is different
from that observed during the first experiment,
when the total lipid values were much lower at
2 Personal communication from E. A. Hawk,
M.D., Department of Clinical Investigation, The
Upjohn Company, Kalamazoo, Michigan.
•Ib. I"
HYPERUPEMIA E.B EXPI2
Fig. III. Electrophoretic Patterns of Hyper-
lipemic Patient (E. B.) Given Intravenous Fat
Emulsion. Experiment II, On Year Following
Experiment I. (A) Fasting Pattern: (B) PatternObtained at the Termination of the Infusion:(C) Pattern Obtained on the Fasting Sample 24
Hours After the Beginning of the Fat Infusion.
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this time than the pre-treatment level. Total
cholesterol remains essentially unchanged in the
second experiment. There is a slight increase in
phospholipids. On the sample taken 24 hours
later, total lipids have dropped considerably,
but are still much higher than pre-treatment
values. Both total cholesterol and phospholipids
have increased.
It is interesting to note that in this experiment,
while the lipid values did not drop below the
pre-treatment level, the corresponding shift
from ar to a-globulin also did not occur.
On the second day of this experiment (Exp. 2),
another IV fat infusion was given. Results of the
lipid studies in this series of experiments are also
recorded in Table III (E. B., Exp. 2). At the
termination of this second infusion, there was a
very large increase in total lipids, almost entirely
in the triglyceride fraction. Total cholesterol
levels were somewhat lower. There was essentially
no change in phospholipids.
The fasting sample taken on the third day
showed a drop in total lipids, although this value
was still nearly twice the pre-treatment level.
Both total cholesterol and phospholipids in-
creased somewhat.
On the third day, another fat infusion (Lipo-
mul-IV) was given (Table III, E. B., Exp. 2),
and a fasting blood sample collected 24 hours
later. A marked drop in total lipids (principally
triglycerides) occurred, although this value is
still considerably higher than the pre-treatment
levels. The same qualitative picture was obtained
for phospholipids, which dropped sharply during
this 24 hour period, but remained higher than the
original level. Cholesterol, essentially unchanged
during the 24 hour period, is also higher than the
pre-treatment level.
The marked drop in total lipids obtained on
the fasting sample taken 24 hours after the third
infusion of Lipomul-IV was accompanied by a
return of the protein fractions to values quantita-
tively similar to those of the pretreatment level.
Qualitatively, the electrophoretic patterns were
characterized by less marked splitting of the
peaks in the a- and f-globulin regions, compared
to the original samples in this experiment.
DISCUSSION
The hyperlipemic patient studied in this
investigation had an electrophoretic pattern
characterized by high values for serum a- and
3-globulin, by low values for ai-globulin, and by
splintering of peaks in the a2- and/or $-globulln
areas. Similar abnormal electrophoretic patterns
were obtained on this patient in several samples,
and on other hyperlipemics which we have
studied.
In the first experiment conducted on this
hyperlipemic patient there was a rapid decrease
in serum lipids as a result of the intravenous fat
infusion. This drop in serum lipids was accom-
panied by an initial increase in ai-globulin and a
decrease in /3-globulin. At the end of 24 hours,
although the total lipid level remained much
lower than pre-infusion levels, the electrophoretic
changes had largely reversed themselves.
In the second experiment the patient responded
not with a decrease in total lipids, but with a
marked increase. The 24 hour fasting sample
showed neither the expected decrease in a-
globulin nor the increase in /3-globulin. The differ-
ence in response of this hyperlipemic patient to
intravenous fat infusion on the two occasions is
difficult to explain satisfactorily.
The findings presented here might be inter-
preted as a reversible transformation of /3- to
a1-lipoprotein as a result of the fat infusion. In
this connection, there are interesting parallels
between the present findings and the work
reported by Herbst, Lever, et al (19) on the
effects of heparin on lipoproteins in hyperlipemia.
These workers (19) found that heparin also
produces an apparent conversion of /3- to a-lipo-
protein. They did not, however, attribute these
results to a conversion of j3- to a-lipoportein, but
to an increase in mobility of j3-lipoproteins by
binding fatty acids resulting from the lipolytic
effect of heparin. If Lever's (19) interpretation is
correct, it would be expected that the administra-
tion of fat emulsions would produce the same
effect in hyperlipemic serum that heparin pro-
duced.
Attention should be called to the presence of a
pre-albumin peak in the samples taken at the
end of the infusion in both experiments. This
finding is again comparable to the work of
llerbst, Lever, et al (19) on the effect of heparin.
These workers attributed the pre-albumin peak
to a combination of a-lipoprotein with fatty
acids, resulting in an a-lipoprotein of increased
mobility.
If it is assumed that not only the conversion of
/3-lipoprotein to a molecule with higher mobility,
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but also the subsequent return of this protein to
its normal mobility, is essential to the lipid-
clearing process, the results of the second experi-
ment, while not explained, at least appear logical.
Electrophoretic patterns obtained during this
experiment showed that, at the end of 24 hours,
while values for total lipid were still elevated,
aj-globulin values were also high, and the area
actually showed two distinct peaks. On this
sample, neither the a2- nor /3-globulins had
returned to pre-treatment levels. While these
findings do not explain the lipid-lowering effect
of fat emulsions, they do show that there is a
direct correlation between the lipid-lowering
effect and the electrophoretic findings. These
findings leave unanswered the essential question
of how fatty acid molecules are removed from
the protein complex.
However interesting such speculations may be,
they do nothing to explain the fact that the
lipid-lowering phenomenon could not be repro-
duced in the same patient one year later. Several
explanations could be offered. It is possible that
marked decreases in serum lipid levels will occur
only in previously untreated patients. It is also
possible that fasting values fluctuate so widely
in these patients from day to day that even the
tremendous change shown may not be signfficant.
It seems unlikely, however, that either of these
possibilities can suffice to explain the discrep-
ancies obtained in the two experiments on the
hyperlipemic patient.
The further possibility exists that the infused
fat (Lipomul-IV) was intrinsically different in
the two experiments on the same patient. The
fact that the samples of Lipomul-IY used in the
two experiments were not identical would tend
to support this hypothesis. In this connec-
tion, it should be noted that Waddell et al (12)
found that the characteristics of the emulsifying
agent have an effect on the rate of clearing.
Kinsell (20) and Bronte-Stewart (21) have also
shown that the degree of saturation of the fatty
acids in the emulsion influences lipid levels.
Further work is currently in progress to investi-
gate this possibility.
Infusions of triglyceride in patients with
idiopathic hyperlipemia have demonstrated that
the lipid transport mechanism in these patients
is basically similar to that of normal individuals.
The clearing process in idiopathic hyperlipemia
is, however, complicated by the great abnormal-
ities, with respect to electrophoretic components
and lipid levels, which these patients demon-
strate.
SUMMARY
The physiological disposition of infused neutral
fats was studied by free electrophoresis and by
quantitative lipid analyses in normal adults and
in patients with idiopathic hyperlipemia. In one
experiment on the hyperlipemic patient a marked
lipid lowering effect of the fat infusion was
demonstrated. This phenomenon, which could not
be repeated on the same patient a year later, is
apparently related to the release of fatty acids
from lipoproteins migrating in the a i-globulin
region. Several possibilities are offered to explain
the differences in results obtained on the two
experiments.
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